BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/21/2022 4:25:35 AM | Browse: 400 | Download: 776
 |
Received |
|
2022-10-19 10:06 |
|
Peer-Review Started |
|
2022-10-19 10:08 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-10-28 09:20 |
|
Revised |
|
2022-10-30 11:08 |
|
Second Decision |
|
2022-11-07 03:26 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-11-07 18:13 |
|
Articles in Press |
|
2022-11-07 18:13 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-11-16 06:38 |
|
Publish the Manuscript Online |
|
2022-11-21 04:25 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Oliver Oey, Yu-Yang Liu, Angela Felicia Sunjaya, Daniel Martin Simadibrata, Muhammad Adnan Khattak and Elin Gray |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Oliver Oey, MD, Doctor, Doctor, Researcher, Department of Internal Medicine, St John of God Midland Public and Private Hospital, Midland, No. 1 Clayton Street, Perth 6004, WA, Australia. oliver.oey@sjog.org.au |
| Key Words |
Melanoma; Gut microbiome; Microbiota; Immunotherapy; Biomarker; Immune checkpoint blockade therapy |
| Core Tip |
Since the introduction of immune checkpoint inhibitors as part of standard of care for melanoma patients, there has been a growing interest in identifying biomarkers of response and immune related adverse events. Amongst these biomarkers, the composition of the gut microbiome has been one of the most intriguing discoveries. Our aim was to ascertain the current published evidence on the gut microbiome diversity and composition as a biomarker of response to immunotherapy. We demonstrated high variability in the results and limited concordance on the organisms identified. We highlight the conflicting aspects of these reports as well as their few commonalities. |
| Publish Date |
2022-11-21 04:25 |
| Citation |
Oey O, Liu YY, Sunjaya AF, Simadibrata DM, Khattak MA, Gray E. Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review. World J Clin Oncol 2022; 13(11): 929-942 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i11/929.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v13.i11.929 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
